The market's opinion of the business has improved over the past year, as indicated by the share price increase outpacing EPS growth. Despite a 0.9% annual reduction in total shareholder return over five years, the business may be reversing its fortunes.
The low P/S ratio indicates a bearish sentiment among Exelixis's shareholders, likely influenced by the company’s underwhelming revenue growth outlook. The current valuation suggests shareholders do not anticipate significant improvements enough to justify a higher P/S ratio.
Selling of shares by insiders below current price can signal negativity to investors, though it's a weak sign. High insider ownership is positive but doesn't negate concerning share sales. Recent lack of insider transactions is seen as neutral.
Gapping up $ジョンソン・エンド・ジョンソン(JNJ.US)$+2.6% (The pharmaceutical giant announced Tuesday it will pay $8.9 billion over the next 25 years to settle claims that the talc in its baby powder and other products caused cancer. J&J also refiled for bankruptcy protection for its LTL Management subsidiary and said it continues to believe the claims lack merit.) $ザイオンズ・バンコープ(ZION.US)$+3.2% (Baird upgraded the regional bank stock to an outper...
RDK79 :
Deutsche Bank initiates today at Buy - PT $124. Would have been nice if they’d done this when it was in the low 80s recently. Looks like Deutche is behind the curve, and wondering if their funds bought in the 80s, then initiated the Buy….
$エクセリクス(EXEL.US)$that will beat expectation -0.03 to 0.23, but limited growth. fda decision day Nov 4. Control you holding size. Could see a gap down (purely buyable), I’ll only buy as early as Friday. update. Pro: good company, good sales growth and promising pipeline. Con: Rude and boring conference cal… Our EPS is not big because they issued a lot of stock and option compensation.
ItzMe17 :
Also any recommendations on go in and exit price? I’m new in the investment and big follower of your picks @Tupack H Mcsnacks.. Thanks for helping novice
エクセリクスに関するコメント
コラムToday's Pre-Market Stock Movers: PLTR, JNJ, ALB, FDX and More
$ジョンソン・エンド・ジョンソン(JNJ.US)$ +2.6% (The pharmaceutical giant announced Tuesday it will pay $8.9 billion over the next 25 years to settle claims that the talc in its baby powder and other products caused cancer. J&J also refiled for bankruptcy protection for its LTL Management subsidiary and said it continues to believe the claims lack merit.)
$ザイオンズ・バンコープ(ZION.US)$ +3.2% (Baird upgraded the regional bank stock to an outper...
コラムToday's pre-market stock movers: RBLX, TTD, VLD, WYNN and more
In reaction to earnings/guidance:
• $トレード・デスク(TTD.US)$+17%,$ワーキバ(WK.US)$ +15.3%,$アーロ・テクノロジーズ(ARLO.US)$ +12%,$アレイ・テクノロジーズ(ARRY.US)$ +10.3%,$エバーブリッジ(EVBG.US)$ +9.7%,$カタリスト・ファーマシューティカルズ(CPRX.US)$ +9.4%,$ハロザイム・セラピューティクス(HALO.US)$ +8.7%,$VELO3D(VLD.US)$ +7.6%,$サイバーアーク・ソフトウェア(CYBR.US)$ + 6.2%,$ヘモネティクス(HAE.US)$ +5.8%,$ジャクソン・フィナンシャル(JXN.US)$ +5.7% (also increases dividend),$アクソン・エンタープライズ(AXON.US)$ +4.8%,...
コラムTop upgrades and downgrades on 6/24: CLR, MRO, SGEN, FUL and more
• $アメリカンウォーターワークス(AWK.US)$ : Janney Upgrades to Buy from Neutral
• $ベクトン・ディッキンソン(BDX.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $アルトリア・グループ(MO.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $ミドルセックス・ウォーター(MSEX.US)$ : Janney Upgrades to Buy from Neutral
• $インドネシア・エネルギー(INDO.US)$ : Noble Capital Upgrades to Outperform from Market Perform - PT...
コラムToday’s pre-market stock movers: ATSG, UAL, LUV, COUP and more
In reaction to earnings/quidance:
• $ギットラブ(GTLB.US)$ +8.8%, $ドール(DOLE.US)$ +2.6%, $トランスユニオン(TRU.US)$ +1.1%
Other news:
-$ホリシス・オートメーション・テクノロジーズ(HOLI.US)$ +12% (report of takeover interest from a company in China)
-$アナベックス・ライフ・サイエンシズ(AVXL.US)$ +10.2% (Phase 2 Clinical Biomarker Data from ANAVEX 2-73-PDD-001)
-$デルタ航空(DAL.US)$ +4.6% (provides 01 update)
-$エア・トランスポート・サービシズ・グループ(ATSG.US)$ +4.3% (plac...
コラムToday’s pre-market stock movers: ATSG, UAL, LUV, COUP and more
- $ホリシス・オートメーション・テクノロジーズ(HOLI.US)$ +12% (report of takeover interest from a company in China)
- $アナベックス・ライフ・サイエンシズ(AVXL.US)$ +10.2% (Phase 2 Clinical Biomarker Data from ANVEX 2-73-PDD-001)
- $デルタ航空(DAL.US)$ +4.6%(povides Q1 update)
- $エア・トランスポート・サービシズ・グループ(ATSG.US)$ +4.3% (places second order with Boeing for the conversion of four 767-300 aircraft)
- $ユナイテッド・エアラインズ・ホールディングス(UAL.US)$ +3.7% (provides Q1 upd...
EPS 0.2
fda decision day Nov 4. Control you holding size. Could see a gap down (purely buyable), I’ll only buy as early as Friday.
update. Pro: good company, good sales growth and promising pipeline.
Con: Rude and boring conference cal… Our EPS is not big because they issued a lot of stock and option compensation.
まだコメントはありません